Name | RTC-30 |
---|
Description | RTC-30 is an optimized phenothiazine with anti-cancer potency. RTC-30 contains a hydroxylated linker (N) that confers increased oral bioavailability[1]. |
---|---|
Related Catalog | |
In Vitro | RTC-30 (0-40 μM; 48 hours) inhibits H1650 lung adenocarcinoma cell growth with an GI50 of 15 μM[1]. Cell Viability Assay[1] Cell Line: H1650 lung adenocarcinoma cells Concentration: 0 μM, 1 μM, 10 μM, 20 μM, 30 μM, 40μM Incubation Time: 48 hours Result: Inhibited H1650 lung adenocarcinoma cell growth. |
References |
Molecular Formula | C24H23F3N2O4S |
---|---|
Molecular Weight | 492.51 |